Adaptimmune Therapeutics
Price & Volume
Stats
See more52W Range | $0.19-$1.48 |
Market Cap | $67M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $179.6M |
Revenue Growth (YoY) | 28.3% |
Gross Profit (12 Mos) | $35.9M |
Diluted EPS | -$0.30 |
News
See moreYahoo Finance • 23 days ago
SA Asks: Which oncology companies are attractive M&A targets?
Yahoo Finance • 2 years ago
Positive week for Adaptimmune Therapeutics plc (NASDAQ:ADAP) institutional investors who lost 68% over the past year
Yahoo Finance • 2 years ago
Adaptimmune to Report Q1 2023 Financial and Business Updates on Friday, May 12, 2023
Yahoo Finance • 2 years ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVT, PTRS, ROCC, ADAP
About
CEO | Mr. Adrian G. Rawcliffe |
Address | 60 Jubilee Avenue, Abingdon, United Kingdom, OX14 4RX |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 506 |
